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E-mail: zmemish@yahoo.comIntroductionMass gatherings pose a health hazard to the attendees through
the transmission of infectious diseases via person-to-person
contact, contaminated food or water, respiratory trans-
mission, and vector-borne transmission. The potential for
outbreaks due to person-to-person transmission, food- and
waterborne disease outbreaks, fast and wide geographic spread
of diseases, and the introduction of non-endemic diseases are
all feared events during mass gatherings. Possible communicable
disease patterns during mass gatherings include: endemic, im-
ported and exported diseases.
Mass gatherings, especially the Hajj, are associated with sig-
niﬁcant international travel. Annually, more than 5 million pil-
grims perform the Hajj or Umrah and these pilgrims come from
184 countries [1,2]. During the Hajj, a large number of pilgrims
gather at the same time in a small area to perform the Hajj
rituals (Figs. 1 and 2). This requirement increases the risk ofClinical Microbiology and Infection © 2014 European Society of Cpresenting potentially harmful communicable diseases in this
population. The journey made by pilgrims is well described [1].
Brieﬂy, in addition to visiting the Holy Mosque in Makkah, pil-
grims visit the Plain of Arafat, Muzdaliffah and Mina. In Mina,
pilgrims stay in tents made speciﬁcally for them (Fig. 2).
Challenges during the Hajj include the strain on healthcare
systems and the difﬁculty in communication of risk because of
language and culture barriers. To overcome the extension of
the healthcare system, the Kingdom of Saudi Arabia established
multiple hospitals and clinics speciﬁcally designated for the Hajj
[1,3,4]. The Saudi Ministry of Health coordinates with the
pertinent authorities in the pilgrims’ countries to develop
suitable material for education and Hajj information [1]. In this
review, we summarize the available literature on the trans-
mission of antibiotic resistance during the Hajj and suggest
possible solutions.Pattern of antibiotic use among pilgrimsPilgrims come from 184 countries, including countries where
antibiotics are available over the counter. The availability of
antibiotics over the counter contributes to increasing resis-
tance [5]. One of the contributing factors to the transmissionClin Microbiol Infect 2015; 21: 109–114
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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FIG. 1. Crowds of pilgrims at Arafat
Mountain.
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otics [6,7]. In a cohort of 820 pilgrims, 84% received antibi-
otics for upper respiratory tract infection [7]. In another study
of 2070 Pakistani pilgrims, 17% had received antibiotics [6].
Ciproﬂoxacin is being used to decrease the rate of throat
colonization with Neisseria meningitidis. In one study, a single
dose of ciproﬂoxacin decreased carriage rate from 8.1% to
zero before and after pilgrimage [8]. Of 177 pilgrims, 92%
were vaccinated with meningococcal quadrivalent vaccine
before the Hajj and 83% received one dose of ciproﬂoxacinClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectbefore leaving Makkah and none had N. meningitidis upon re-
turn from the Hajj [9]. The current recommendations call for
a single dose of ciproﬂoxacin and ACYW135 meningococcal
vaccine for visitors from the African meningitis belt: Benin,
Burkina Faso, Cameroon, Chad, Central African Republic,
Côte d’Ivoire, Eritrea, Ethiopia, Gambia, Guinea, Guinea-
Bissau, Mali, Niger, Nigeria, Senegal and Sudan [3,10]. From
2005 to 2010, about 250 000 to 460 000 pilgrims receive the
recommended ciproﬂoxacin prophylaxis at the port of entry in
Saudi Arabia [4].FIG. 2. Arial view of the tents of
pilgrims at Mina.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 109–114
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antibiotic resistanceContributing factors for the spread of drug resistance organ-
isms include: international travel, misuse of antibiotics, avail-
ability of antibiotics over the counter, knowledge, and attitude
and practice towards antibiotics [11]. Lack of potable water,
poor hygiene, inadequate sanitary facilities and limited access
to soap and water may all contribute to the dissemination of
bacterial pathogens [12]. The dissemination of antimicrobial-
resistant organisms across international borders is a well-
recognized phenomenon [13]. Transmission of New Delhi
metallo-β-lactamase (NDM-1) internationally was conﬁrmed
in numerous countries across the world [14]. Transmission of
extended spectrum β-lactamase-producing bacteria was
associated with international travel [15,16]. SHV-12-producing
Salmonella typhi, CTX-M-14-producing Salmonella, CTX-M-15-
producing Shigella sonnei and CTX-M-producing Escherichia coli
[17,18]. van der Bij and Pitout recently summarized 40
different studies describing the role of travellers in the spread
of multidrug-resistant organisms such as between different
countries [19]. The spread of certain organisms such as Kleb-
siella pneumoniae carbapenemase-producing Enter-
obacteriaceae and Enterobacteriaceae producing metallo-
β-lactamases (VIM, IMP and NDM) was based on case reports,
whereas retrospective case studies, prospective population-
based surveillance and case–control studies conﬁrmed the
transmission of extended spectrum β-lactamase- and CTX-M-
14 producing organisms [19].
Introduction of drug-resistant organisms to different parts of
the world with subsequent secondary outbreaks may be
exaggerated in mass gatherings. In 1987, antibiotic-resistant
Shigella sonnei infection was recognized in a mass gathering
event [20].Role of pilgrims in the dissemination of
antibiotic resistanceFew studies are available concerning the transmission and
acquisition of antibiotic resistance during Hajj. Pilgrims acquired
antibiotic non-susceptible Streptococcus pneumoniae at a rate of
6.1% compared with 2.5% pretravel and had increased acqui-
sition of multiple drug-resistant S. pneumoniae from 0.6% to
2.2% [21]. It has been reported that as many as one-third of
pilgrims acquire S. pneumoniae during the Hajj [22].
Travellers’ diarrhoea may occur in pilgrims and self-
administered antibiotics such as azithromycin or ciproﬂoxacin
are usually recommended for moderate to severe travellers’Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiologydiarrhoea [2]. Pilgrims were also advised to carry a 3-day
course of antibiotic therapy and an anti-motility agent [23].
Evaluation of a small number of pilgrims showed that 85 of
411 (20.6%) were positive for Staphylococcus aureus, and only 6
(1.46%) were methicillin-resistant Staphylococcus aureus (MRSA)
[24]. The reason for the low prevalence might be related to the
use of prophylactic ciproﬂoxacin [24]. However, the study was
old and there is increasing prevalence of MRSA in the com-
munity so the transmission of MRSA is possible among pilgrims
due to their close proximity during the Hajj rituals. Such out-
breaks were reported in those living in close proximity [25].
Staphylococcus aureus was isolated from 129 (8.5%) of 1516
clinical specimens from food handlers in Makkah [26]. The
transmission of Staphylococcus aureus during Hajj and Umrah
was evaluated in one study. Nasal swabs were taken from 979
Umrah visitors and 613 pilgrims before and after performing
Umrah and Hajj. It was interesting to note that the study
showed that Umrah increased the carriage rate from 15.8% to
24%; whereas the carriage rates in pilgrims performing the Hajj
were 25% and 20.9% before and after the Hajj [27].Transmission of meningococcal diseaseThe transmission of N. meningitidis infection during the Hajj is
well studied [1,4]. Two major outbreaks of N. meningitidis
occurred during the Hajj, in 1987 and in 2000–2001 [1,4]
(Fig. 3). These outbreaks resulted in the introduction of
mandatory meningococcal vaccines initially of the bivalent (A
and B) and later of the quadrivalent (ACYW135) meningo-
coccal vaccines. In a recent study examining the resistance
pattern of N. meningitidis among pilgrims, 8.3% before Hajj and
10.3% after Hajj were resistant to azithromycin; however, only
5% of the isolates were resistant to ciproﬂoxacin [28].Risk of transmission of tuberculosisThe risk of the transmission of tuberculosis (TB), and especially
multidrug-resistant and extensively drug-resistant TB, in mass
gatherings is a real concern. Many factors facilitate the trans-
mission of respiratory tract infections during the Hajj, including
overcrowding, close proximity of pilgrims and poor personal
hygiene [29]. It was estimated that about half of pilgrims come
from areas with a high prevalence of TB such as India, Pakistan
Bangladesh, Southeast Asia and Africa [30]. A summary of
different studies addressing TB among pilgrims is shown in Table 1
[30–36]. It is thought that the inﬂux of international pilgrims
contributed to a higher rate of TB resistance in the Makkah and
Madinah regions than in the rest of Saudi Arabia [2,23,37,38].and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 109–114
FIG. 3. Time line of meningococcal
disease during the Hajj.
112 Clinical Microbiology and Infection, Volume 21 Number 2, February 2015 CMIMillions of pilgrims visit the country for Islamic rituals, so
screening for active TB is not possible at port of entry [39,40].
Screening at the country of origin seems more rewarding but
more complex to implement [30].Blood-borne pathogensThe risk of blood-borne pathogens during pilgrimage is of
particular concern during head-shaving rituals. In one study
comparing human immunodeﬁciency virus-positive pilgrims and
non-pilgrims it was found that antiretroviral failure was more
common among pilgrims (15/31; 48.4%) than non-pilgrims (5/
27; 18.5%) [41]. The potential for dissemination of blood-borne
disease during the Hajj is limited due to the nature of the ac-
tivities being performed by the pilgrims. One of the potential
risks for the spread of blood-borne pathogens, including
multidrug-resistant human immunodeﬁciency virus infections, is
through shaving of head hair during the Hajj rituals. Men ﬁnish
their pilgrimage by shaving their heads, so the Saudi government
has prevented unlicensed barbers and created licensed bar-
bershops [4].TABLE 1. A summary of studies of tuberculosis during the Hajj
Population Number % TB TB Class Reference
Fatal pneumonia 30 10 active [30]
Pilgrims 149 15 IGRA conversion [31]
Admitted 46 20 active TB [32]
Admitted 808 1.2 active [33]
Admitted 140 4.9 old TB [34]
Admitted 452 4.9 active [35]
Symptoms of respiratory
tract infections
118 1 active [36]
Abbreviations: IGRA, interferon-γ release assay; TB, tuberculosis.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectPossible solutionsSince the majority of drug-resistant organisms are transmitted
through direct contact, improvement in infection control
among pilgrims and in clinics in the Hajj area is an important
factor. Periodic audits of hospital infection control resulted in a
signiﬁcant improvement in infection control in six community
hospitals in Makkah [42].
Any intervention to decrease antibiotic resistance across the
globe should take into consideration patient safety, local needs
and sustainability of interventions such as educational campaigns
to the population, pilgrims and healthcare professionals [5].
Better diagnostics and therapeutics are essential to combat the
global spread of antimicrobial resistance [43,44]. The develop-
ment of point-of-care diagnostic tests would further enhance
the ability to differentiate bacterial from viral infections and so
decrease antibiotic use. To enhance treatment outcomes for
patients with infections requires rapid, accurate diagnosis and
more effective, pathogen-speciﬁc therapies [45]. Availability of
effective vaccines for emerging infectious diseases would
further curtail the spread of these pathogens in mass gatherings.
Continued surveillance to detect the emergence of new or
drug-resistant pathogens using effective international collabo-
rative centres ensures rapid identiﬁcation of these pathogens
with the application of control measures [46]. There is no single
bullet to combat antimicrobial resistance and a multifaceted,
collaborative, international approach is needed. A global
approach should be tried to address problems in public health
and identify knowledge gaps; measuring short-term and long-
term solutions; evaluating obstacles to execution; and setting
out schemes for the control of infectious diseases [47]. Solu-
tions should extend beyond antibiotic use in humans. In theious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 109–114
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[48]. In the Kingdom of Saudi Arabia, two studies showed
antibiotic supplementation of animal feed [49,50]. The use of
antibiotics in agriculture and aquaculture exposes bacteria to
sub-inhibitory concentrations of antibiotics, leading to
increased resistance [51]. Antibiotic use in agriculture and
aquaculture is associated with selection of bacterial resistance
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